Finally, monoamine oxidase B (MAO-B) inhibitors, such as selegiline, rasagiline and safinamide (Figure 2) aims to alleviate PD symptoms by inhibiting the brain enzyme MAO-B, so preventing the breakdown of dopamine in the brain. Here, MAOB is linked to Parkinson disease.